Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.
about
Simultaneous adrenal and extra-adrenal myelolipoma - an uncommon incident: case report and review of the literatureChildren's Oncology Group's 2013 blueprint for research: Soft tissue sarcomasMusculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniquesProton MR spectroscopy in metabolic assessment of musculoskeletal lesionsBone versus soft-tissue sarcomas in the elderly.Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas.Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma.Radiation therapy for palliation of sarcoma metastases: a unique and uniform hypofractionation experience.Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial ProtocolFDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas.Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cellsChemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapyComplete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcomaPosttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study.Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials.Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxaneQuantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignPrognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.Texture Analysis of Non-Contrast-Enhanced Computed Tomography for Assessing Angiogenesis and Survival of Soft Tissue Sarcoma.18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy.3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.PEComa of the Upper Extremity: A Unique Case and Description of an Initial Response to Neoadjuvant Chemotherapy.Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging SequencesPrognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.Hypofractionated adjuvant radiation therapy of soft-tissue sarcoma achieves excellent results in elderly patientsMultimodality treatment of locally advanced soft-tissue sarcomas of the extremities.Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study
P2860
Q21245583-2A5ABAB3-8379-401D-8C08-08CD01A7E988Q26825000-C50CA945-808F-413E-8C25-C93760183D73Q26828595-CE9522D3-0FB3-4DF8-B1DD-DFB938916D4EQ26851361-AAD67DF9-EB70-4396-9262-93FF9389ABCCQ33273787-B9DAB272-1D01-4772-A6EA-D3AB2F9EF134Q33398802-C7304ABC-2A17-478A-B043-1DB690A7093CQ33641267-A5B58D00-D832-400F-A4A3-0CCD86289301Q33656296-9C19A8D7-604A-4E66-B7DA-5A10A7019E2DQ33660219-CF9B30B3-AEBD-497C-BE67-628F7B82631CQ33712869-714AE969-4DD8-4B7B-B8F4-862F821A1DFAQ33757142-8ADC6A5F-3DDE-4BD3-9087-8C050632F2DCQ33781004-E2C308ED-D8A5-4F38-998F-E050F037C08EQ33797361-8E0DE95A-CC9A-4DCD-BBC8-C68647D93780Q33797380-9A640C8C-A8BB-4756-BA3D-DA83BB57848FQ33800218-9D345400-DD44-4A87-B7BA-964658FD1AA6Q33976797-F1981326-50B6-4CD2-AB6B-6911CE5C59D1Q34045393-3E843E8B-A407-427F-BB22-75AF4E5B7F08Q34097124-4A88DCCB-44A7-4505-BCED-CEA65C0AC90EQ34129461-466ADDE4-BBCE-4E41-9A6B-05A524939D43Q34129496-2CB88323-E520-4987-BEE2-BBD81A0E9723Q34138698-110B164D-F50B-46F0-B66C-D1A413824E9CQ34163791-CB24272D-B878-4A03-A638-43A52332B047Q34340824-D3A0099D-0225-4393-B549-B94F0C9DA575Q34550639-22AD5C20-B79C-45B6-8083-D902AD7264ADQ34580595-910C9D2B-3701-4557-9AB3-35C4F2F4F18FQ34638659-03DBAA04-7AE1-471E-BB00-F6AB9D61A421Q34655297-40B53586-0CF9-4517-8470-2E4413F0C432Q34795318-1B6133BA-3B19-4F94-905F-DDF3EE4E34BFQ35288214-6CB7B652-5031-483B-82B5-07E63FDD6E88Q35677857-5C6BAA69-B115-47EC-8F94-614050630650Q35858640-E3980ED1-A0D8-4E51-BBB9-2F014B0D8F5BQ36201687-867CE6C5-0E5F-42A3-B8AF-71D6F1B15FF7Q36217442-24024251-0699-449C-B922-435B5BA45C74Q36426773-EA129A2C-8AD6-4A91-B798-8709B7B246B7Q36630226-26C7027A-5F22-494B-8C97-9CDC683E8740Q36753430-161B6184-A1DA-43B3-A993-4EC1D2BE9382Q36973569-F97CE5F0-F316-4651-92AD-509BCE296CE5Q37099039-1290620A-DA4C-4D34-860E-A5B577CCB60FQ37392082-84959751-33EC-46EC-B457-874A3CAF9A3DQ37426036-8DADA71F-855A-4F91-8023-8C84B4E35839
P2860
Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@en
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@nl
type
label
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@en
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@nl
prefLabel
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@en
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@nl
P2093
P1476
Treatment-induced pathologic n ...... xtremity soft tissue sarcomas.
@en
P2093
C Forscher
F C Eilber
F R Eilber
S D Nelson
P304
P356
10.1200/JCO.2001.19.13.3203
P407
P577
2001-07-01T00:00:00Z